DIGNA BIOTECH

Digna Biotech aims to implement preclinical studies and run clinical trials to document the existing products. This provides requisite documentary evidence to enter into licensing agreements with pharmaceutical companies. The various products discovered and patented by CIMA are added to the Digna Biotech pipeline so the company can continue product development to the clinical phase. At that stage, the product is licensed out to a pharmaceutical company, which completes the process and markets the drug. The aim of Digna Biotech is to make new treatments available to patients.

The following slides provide a summary of the products that Digna Biotech is developing as well as the drug indications. The graphics show the pipeline of the entire company product portfolio.

Therapeutic area

Digna Biotech Pipeline therapeutic products:

Diagnostic area

Digna Biotech Pipeline diagnostic products: